| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Class A Common Stock | Options Exercise | $288,000 | +75,000 | +18% | $3.84* | 497,037 | 21 Nov 2022 | Direct | F1, F2 |
| transaction | EVH | Class A Common Stock | Sale | $2,009,250 | -75,000 | -15% | $26.79 | 422,037 | 21 Nov 2022 | Direct | F1, F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Class A Common Option (right to buy) | Options Exercise | $0 | -75,000 | -40% | $0.000000 | 111,040 | 21 Nov 2022 | Class A Common Stock | 75,000 | $3.84 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022. |
| F2 | Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.38 to $27.10, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F4 | The Class A Common Stock Options exercised vested on December 1, 2016, and December 1, 2017. |